BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38201498)

  • 1. Changing Prevalence of AIDS and Non-AIDS-Defining Cancers in an Incident Cohort of People Living with HIV over 28 Years.
    Cattelan AM; Mazzitelli M; Presa N; Cozzolino C; Sasset L; Leoni D; Bragato B; Scaglione V; Baldo V; Parisi SG
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and trend of AIDS-defining cancers and non-AIDS-defining cancers and their association with antiretroviral therapy among people living with HIV in South Carolina: a population-based cohort study.
    Nkwonta CA; Zhang J; Chen S; Weissman S; Olatosi B; Li X
    AIDS Care; 2023 May; 35(5):753-763. PubMed ID: 35578401
    [No Abstract]   [Full Text] [Related]  

  • 3. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
    Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
    Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer in HIV-infected persons from the Caribbean, Central and South America.
    Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
    Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
    Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after cancer diagnosis in a cohort of HIV-positive individuals in Latin America.
    Fink VI; Jenkins CA; Castilho JL; Person AK; Shepherd BE; Grinsztejn B; Netto J; Crabtree-Ramirez B; Cortés CP; Padgett D; Jayathilake K; McGowan C; Cahn P;
    Infect Agent Cancer; 2018; 13():16. PubMed ID: 29760767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.
    Long JL; Engels EA; Moore RD; Gebo KA
    AIDS; 2008 Feb; 22(4):489-96. PubMed ID: 18301061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area.
    Castel AD; Young H; Akiwumi AM; Vargas A; Rogers K; West T; Levine PH
    AIDS Care; 2015; 27(7):860-9. PubMed ID: 25714364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort study.
    Szychowiak P; Boulain T; Timsit JF; Elabbadi A; Argaud L; Ehrmann S; Issa N; Canet E; Martino F; Bruneel F; Quenot JP; Wallet F; Azoulay É; Barbier F
    Ann Intensive Care; 2023 Aug; 13(1):74. PubMed ID: 37608140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities and co-medications among 28 089 people living with HIV: A nationwide cohort study from 2009 to 2019 in Japan.
    Naito T; Suzuki M; Fukushima S; Yuda M; Fukui N; Tsukamoto S; Fujibayashi K; Goto-Hirano K; Kuwatsuru R
    HIV Med; 2022 May; 23(5):485-493. PubMed ID: 34821006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort.
    Poizot-Martin I; Lions C; Allavena C; Huleux T; Bani-Sadr F; Cheret A; Rey D; Duvivier C; Jacomet C; Ferry T; Cabie A; Fresard A; Pugliese P; Delobel P; Lamaury I; Chirouze C; Zaegel-Faucher O; Brégigeon S; Rojas Rojas T; Obry-Roguet V; Makinson A
    Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):554-563. PubMed ID: 33310788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Non-HIV Malignancies Increased in the HIV-Infected Population?
    Thrift AP; Chiao EY
    Curr Infect Dis Rep; 2018 May; 20(8):22. PubMed ID: 29804238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up.
    Suárez-García I; Gutierrez F; Pérez-Molina JA; Moreno S; Aldamiz T; Valencia Ortega E; Curran A; Gutiérrez González S; Asensi V; Amador Prous C; Jarrin I; Rava M;
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18161-18171. PubMed ID: 38008809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and the risk of cancers with and without a known infectious cause.
    Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
    AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.
    Meijide H; Pértega S; Rodríguez-Osorio I; Castro-Iglesias Á; Baliñas J; Rodríguez-Martínez G; Mena Á; Poveda E
    AIDS; 2017 May; 31(8):1099-1107. PubMed ID: 28441174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.
    Bruyand M; Ryom L; Shepherd L; Fatkenheuer G; Grulich A; Reiss P; de Wit S; D Arminio Monforte A; Furrer H; Pradier C; Lundgren J; Sabin C;
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):568-77. PubMed ID: 25763785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
    Masiá M; Padilla S; Estañ G; Portu J; Silva A; Rivero A; González-Cordón A; García-Fraile L; Martínez O; Bernal E; Galera C; Boix Martínez V; Macias J; Montero M; García-Rosado D; Vivancos-Gallego MJ; Llenas-García J; Torralba M; García JA; Agulló V; Fernández-González M; Gutiérrez F; Martínez E;
    Trials; 2021 Nov; 22(1):851. PubMed ID: 34838115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.
    Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; De Wit S; Phillips A; Lundgren JD; Sabin CA;
    BMC Infect Dis; 2013 Oct; 13():471. PubMed ID: 24106926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing Patterns of lung, liver, and head and neck non-AIDS-defining cancers relative to HIV status in Tanzania between 2002-2014.
    Campbell JA; Soliman AS; Kahesa C; Harlow SD; Msemo D
    Infect Agent Cancer; 2016; 11():58. PubMed ID: 27895703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
    Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
    Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.